The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Abstract
Clonal hematopoiesis of indeterminate potential (CHIP) occurs in an age-related manner and associates with an increased risk of hematologic cancer, atherosclerotic disease, and shorter overall survival. Little is known about the cell of origin, repartition patterns of clonal mutations within the hematopoietic differentiation tree, and its dynamics under evolutionary pressure. Using targeted sequencing, CHIP was identified in 121 out of 437 elderly individuals (27.7%). Variant allele frequencies (VAFs) of 91 mutations were studied in six peripheral blood cell fractions. VAFs were significantly higher in monocytes, granulocytes, and NK-cells compared to B- or T cells. In all cases with available bone marrow material, mutations could be identified in Lin - CD34 + CD38 - HSCs with subsequent expansion to myeloid primed progenitors. In 22 patients with solid cancer receiving (radio-)chemotherapy, longitudinal study of 32 mutations at 121 time points identified relative VAF changes of at least 50% in 13/32 mutations. VAFs of DNMT3A, were stable in 12/13 cases (P < .001). Cancer patients with a clonal mutation other than DNMT3A required more often red blood cell transfusions and dose reductions. Our results provide novel insights into cellular distribution of clonal mutations, their dynamics under chemotherapy, and advocate for systematic analyses for CHIP in cancer patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CHIP mutations originate in multipotent HSCs, the clonal progeny is predominantly concentrated within the myeloid compartment, specifically affecting monocytes and granulocytes, with a significantly lower mutational burden observed in lymphoid cells [29].”
From Clonal Hematopoiesis of Indeterminate Potential as an Emerging Interdisciplinary Risk Factor in Alzheimer’s Disease: Current Evidence and Future Directions (2026) · cites this paper as [29]
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,073
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Thorvaldsdottir, H., Robinson, J. T., & Mesirov, J. P. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs017 · Cited by 9,049
Aligning sequence reads, clone sequences and assembly con*gs with BWA-MEMPreprint
Li, H. (2014) · arXiv (Cornell University) · doi:10.6084/m9.figshare.963153.v1 · Cited by 5,155
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Cited by
Sorted by citations
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
Boettcher, S., Miller, P. G., Sharma, R., McConkey, M., Leventhal, M., Krivtsov, A. V., Giacomelli, A. O., Wong, W., Kim, J., Chao, S., et al. (2019) · Science · doi:10.1126/science.aax3649 · Cited by 441
Caiado, F., Pietras, E. M., & Manz, M. G. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201541 · Cited by 289
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Chen, J., Kao, Y.-R., Sun, D., Todorova, T. I., Reynolds, D. M., Narayanagari, S.-R., Montagna, C., Will, B., Verma, A. K., & Steidl, U. G. (2018) · Nature Medicine · doi:10.1038/s41591-018-0267-4 · Cited by 239
Mas‐Peiró, S., Hoffmann, J., Fichtlscherer, S., Dorsheimer, L., Rieger, M. A., Dimmeler, S., Vasa‐Nicotera, M., & Zeiher, A. M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz591 · Cited by 248
Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation
Frick, M., Chan, W., Arends, C. M., Hablesreiter, R., Halik, A., Heuser, M., Michonneau, D., Blau, O., Hoyer, K., Christen, F., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2184 · Cited by 223
Self-citationFuster, J. J., Zuriaga, M. A., Zorita, V., MacLauchlan, S., Polackal, M. N., Viana-Huete, V., Ferrer-Pérez, A., Matesanz, N., Herrero-Cervera, A., Sano, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108326 · Cited by 204
Clonal hematopoiesis and non-hematologic disorders
Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182
JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Sano, S., Wang, Y., Yura, Y., Sano, M., Oshima, K., Yang, Y., Katanasaka, Y., Min, K.-D., Matsuura, S., Ravid, K., et al. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.013 · Cited by 170
Clonal haematopoiesis and dysregulation of the immune system
Belizaire, R., Wong, W. J., Robinette, M. L., & Ebert, B. L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00843-3 · Cited by 161
Carlsten, M., & Järås, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02357 · Cited by 156
Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
Cook, E. K., Izukawa, T., Young, S., Rosen, G., Jamali, M., Zhang, L., Johnson, D., Bain, E., Hilland, J., Ferrone, C. K., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018024729 · Cited by 153
Christen, F., Hoyer, K., Yoshida, K., Hou, H., Waldhüter, N., Heuser, M., Hills, R. K., Chan, W., Hablesreiter, R., Blau, O., et al. (2019) · Blood · doi:10.1182/blood-2018-05-852822 · Cited by 144
Self-citationNam, A. S., Dusaj, N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M., Gaiti, F., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01179-9 · Cited by 140
Zhang, C. R. C., Nix, D., Gregory, M., Ciorba, M. A., Ostrander, E. L., Newberry, R. D., Spencer, D. H., & Challen, G. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.11.008 · Cited by 137
Jakobsen, N. A., Turkalj, S., Zeng, A. G. X., Stoilova, B., Metzner, M., Rahmig, S., Nagree, M. S., Shah, S., Moore, R., Usukhbayar, B., et al. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.05.010 · Cited by 130
Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 124
Gu, X., Ebrahem, Q., Mahfouz, R. Z., Hasipek, M., Enane, F. O., Radivoyevitch, T., Rapin, N., Przychodzen, B. P., Hu, Z., Balusu, R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97117 · Cited by 118
Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling
Ococks, E., Frankell, A. M., Masqué‐Soler, N., Grehan, N., Northrop, A., Coles, H., Redmond, A. M., Devonshire, G., Weaver, J. M. J., Hughes, C. D., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.010 · Cited by 114
Groarke, E. M., & Young, N. S. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.001 · Cited by 109
Arends, C. M., Liman, T. G., Strzelecka, P. M., Kufner, A., Löwe, P., Huo, S., Stein, C. M., Piper, S. K., Tilgner, M., Sperber, P. S., et al. (2023) · Blood · doi:10.1182/blood.2022017661 · Cited by 99
Self-citationClonal Hematopoiesis and Risk of Incident Lung Cancer
Tian, R., Wiley, B. J., Liu, J., Zong, X., Truong, B. M. T., Zhao, S., Uddin, M. M., Niroula, A., Miller, C. A., Mukherjee, S., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00857 · Cited by 96
Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
Arends, C. M., Weiß, M., Christen, F., Eulenberg-Gustavus, C., Rousselle, A., Kettritz, R., Eckardt, K., Chan, W., Hoyer, K., Frick, M., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.223305 · Cited by 89
Self-citationBoettcher, S., Wilk, C. M., Singer, J., Beier, F., Burcklen, E., Beisel, C., Ferreira, M. S. V., Gourri, E., Gassner, C., Frey, B. M., et al. (2020) · Blood · doi:10.1182/blood.2019003079 · Cited by 80
Ferrone, C. K., Blydt-Hansen, M., & Rauh, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020626 · Cited by 80
Environmental influences on clonal hematopoiesis
King, K. Y., Huang, Y., Nakada, D., & Goodell, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.005 · Cited by 75
Chavakis, T., Wielockx, B., & Hajishengallis, G. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-052521-013627 · Cited by 75
Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis
Stacey, S., Zink, F., Halldorsson, G. H., Stefánsdóttir, L., Gudjonsson, S. A., Einarsson, G., Hjörleifsson, G., Eiriksdottir, T., Helgadóttir, A., Björnsdóttir, G., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01555-z · Cited by 71
Single-cell analysis based dissection of clonality in myelofibrosis
Mylonas, E., Yoshida, K., Frick, M., Hoyer, K., Christen, F., Kaeda, J., Obenaus, M., Noerenberg, D., Hennch, C., Chan, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13892-x · Cited by 72
Self-citationClonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Hajishengallis, G., Li, X., Divaris, K., & Chavakis, T. (2022) · Periodontology 2000 · doi:10.1111/prd.12421 · Cited by 70
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
Lundgren, S., Keränen, M. A. I., Kankainen, M., Huuhtanen, J., Walldin, G., Kerr, C. M., Clemente, M. J., Ebeling, F. T., Rajala, H. L. M., Brück, O. E., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01231-3 · Cited by 63
Self-citationOrtmann, C. A., Dorsheimer, L., Abou‐El‐Ardat, K., Hoffrichter, J., Aßmus, B., Bonig, H. B., Scholz, A., Pfeifer, H., Martin, H., Schmid, T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.064 · Cited by 61
Arends, C. M., Dimitriou, S., Stahler, A., Hablesreiter, R., Strzelecka, P. M., Stein, C. M., Tilgner, M., Saiki, R., Ogawa, S., Bullinger, L., et al. (2021) · Blood · doi:10.1182/blood.2021014108 · Cited by 60
Self-citationWong, W., Bhatt, S. T., Trinkaus, K. M., Pusic, I., Elliott, K., Mahajan, N., Wan, F., Switzer, G. E., Confer, D. L., DiPersio, J. F., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax6249 · Cited by 52
Aggressive Lymphoma after CD19 CAR T-Cell Therapy
Kobbe, G., Brüggemann, M., Baermann, B., Wiegand, L., Trautmann, H., Yousefian, S., Libertini, S., Menssen, H. D., Maier, H. J., Ulrich, P. C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2402730 · Cited by 60
Self-citationDevelopmental and temporal characteristics of clonal sperm mosaicism
Yang, X., Breuss, M. W., Xu, X., Antaki, D., James, K. N., Stanley, V., Ball, L., George, R. D., Wirth, S. A., Cao, B., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.024 · Cited by 55
Yang, S., Xu, J., Dai, Y., Jin, S., Sun, Y., Li, J., Liu, C.-L., Ma, X., Zhu, C. H., Chen, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44648-3 · Cited by 54
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation
Boy, M., Bisio, V., Zhao, L., Guidez, F., Schell, B., Lereclus, E., Henry, G., Villemonteix, J., Rodrigues‐Lima, F., Gagne, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36193-w · Cited by 51
Ageing, immune fitness and cancer
Dolan, M., Libby, K. A., Ringel, A. E., van Galen, P., & McAllister, S. S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00858-z · Cited by 55
Clonal hematopoiesis and its emerging effects on cellular therapies
Bonin, M. V., Jambor, H. K., Teipel, R., Stölzel, F., Thiede, C., Damm, F., Kroschinsky, F., Schetelig, J., Chavakis, T., & Bornhäuser, M. (2021) · Leukemia · doi:10.1038/s41375-021-01337-8 · Cited by 50
Self-citationCHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression
Liu, X., Sato, N., Shimosato, Y., Wang, T., Denda, T., Chang, Y., Yabushita, T., Fujino, T., Asada, S., Tanaka, Y., et al. (2022) · Cancer Science · doi:10.1111/cas.15294 · Cited by 42
Clonal hematopoiesis: Pre-cancer PLUS
Silver, A. J., & Jaiswal, S. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.003 · Cited by 46
Eskelund, C. W., Husby, S., Favero, F., Klausen, T. W., Rodríguez-González, F. G., Kolstad, A., Pedersen, L. B., Räty, R., Geisler, C. H., Jerkeman, M., et al. (2020) · Blood · doi:10.1182/blood.2019003539 · Cited by 45
Tanaka, T. N., Morita, K., Loghavi, S., Wang, F., Furudate, K., Sasaki, Y., Little, L., Gumbs, C. E., Matthews, J. A., Daver, N. G., et al. (2021) · Blood · doi:10.1182/blood.2020010483 · Cited by 43
Clonal haematopoiesis, ageing and kidney disease
Vlasschaert, C., Lanktree, M. B., Rauh, M. J., Kelly, T. N., & Natarajan, P. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00778-x · Cited by 42
Heimlich, J. B., Bhat, P. K., Parker, A., Jenkins, M. T., Vlasschaert, C., Ulloa, J., Amburg, J. C. V., Potts, C. R., Olson, S., Silver, A. J., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011445 · Cited by 50
Kiefer, K. C., Cremer, S., Pardali, E., Aßmus, B., Abou‐El‐Ardat, K., Kirschbaum, K., Dorsheimer, L., Rasper, T., Berkowitsch, A., Serve, H. L., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13297 · Cited by 46
Clonal hematopoiesis: Molecular and clinical implications
Kusne, Y. N., Xie, Z., & Patnaik, M. M. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106787 · Cited by 43
Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients
Panagiota, V., Kerschbaum, J. F., Penack, O., Stein, C. M., Arends, C. M., Koenecke, C., Strzelecka, P. M., Kloos, A., Wiegand, L., Lasch, A., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000957 · Cited by 44
Self-citationClonal hematopoiesis and its impact on the aging osteo-hematopoietic niche
Winter, S., Götze, K. S. S., Hecker, J. S., Metzeler, K. H., Guezguez, B., Woods, K., Medyouf, H., Schäffer, A., Schmitz, M., Wehner, R., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02226-6 · Cited by 46
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
Arends, C. M., Kopp, K., Hablesreiter, R., Estrada, N., Christen, F., Moll, U. M., Zeillinger, R., Schmitt, W., Sehouli, J., Kulbe, H., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02253-3 · Cited by 45
Self-citationClonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications
Hartmann, L., & Metzeler, K. H. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22756 · Cited by 42
Shin, T., Zhou, Y., Chen, S., Cordes, S., Grice, M. Z., Fan, X., Lee, B., Aljanahi, A. A., Hong, S. G., Vaughan, K. L., et al. (2022) · Blood · doi:10.1182/blood.2021014875 · Cited by 39
Stem cell donors should not be screened for clonal hematopoiesis
Gibson, C. J., & Lindsley, R. C. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000395 · Cited by 33
Mitchell, K., & Steidl, U. G. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036251 · Cited by 37
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
Kusne, Y. N., Fernandez, J. A., & Patnaik, M. M. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.10.004 · Cited by 34
Wu, D., Luo, X., Feurstein, S. K., Kesserwan, C. A., Mohan, S., Álvarez, D. E. P., & Godley, L. A. (2020) · Haematologica · doi:10.3324/haematol.2018.214221 · Cited by 33
Newell, L. F., Williams, T. P., Liu, J., Yu, Y., Chen, Y., Booth, G. C., Knight, R. J., Goslee, K., Cook, R. J., Leonard, J. T., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.04.014 · Cited by 32
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
Papa, V., Marracino, L., Fortini, F., Rizzo, P., Campo, G. C., Vaccarezza, M., & Sega, F. V. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082480 · Cited by 29
Association of Somatic TET2 Mutations With Giant Cell Arteritis
Robinette, M. L., Weeks, L. D., Kramer, R. J., Agrawal, M., Gibson, C. J., Yu, Z., Sekar, A., Mehta, A., Niroula, A., Brown, J. T., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42738 · Cited by 29
Hoyer, K., Hablesreiter, R., Inoue, Y., Yoshida, K., Briest, F., Christen, F., Kakiuchi, N., Yoshizato, T., Shiozawa, Y., Shiraishi, Y., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103327 · Cited by 26
Self-citationAged healthy mice acquire clonal hematopoiesis mutations
Chin, D. W. L., Yoshizato, T., Culleton, S. V., Grasso, F., Barbachowska, M., Ogawa, S., Jacobsen, S. E. W., & Woll, P. S. (2021) · Blood · doi:10.1182/blood.2021014235 · Cited by 27
Self-citationNowakowska, M. K., Kim, T., Thompson, M. T., Bolton, K. L., Deswal, A., Lin, S. H., Scheet, P. A., Wehner, M. R., & Nead, K. T. (2022) · American Journal of Hematology · doi:10.1002/ajh.26465 · Cited by 28
Clonal Hematopoiesis and therapy related MDS/AML
Desai, P. M., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.02.006 · Cited by 28
Krishnan, V., Kim, D. D. H., Hughes, T. P., Branford, S., & Ong, S. T. (2021) · Haematologica · doi:10.3324/haematol.2021.279317 · Cited by 27
Somatic mutations and T-cell clonality in patients with immunodeficiency
Savola, P., Martelius, T., Kankainen, M., Huuhtanen, J., Lundgren, S., Koski, Y., Eldfors, S., Kelkka, T., Keränen, M. A. I., Ellonen, P., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.220889 · Cited by 25
p53 biology and reactivation for improved therapy in MDS and AML
Zawacka‐Pankau, J. (2024) · Biomarker Research · doi:10.1186/s40364-024-00579-9 · Cited by 25
Truty, R., Rojahn, S., Ouyang, K., Kautzer, C., Kennemer, M. I., Álvarez, D. E. P., Johnson, B. A., Stafford, A., Basel‐Vanagaite, L., Saitta, S. C., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.02.013 · Cited by 28
The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
Nawas, M. T., Schetelig, J., Damm, F., Levine, R. L., Perales, M., Giralt, S., van den Brink, M. R. M., Arcila, M. E., Zehir, A., Papaemmanuil, E., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100744 · Cited by 23
Self-citationSRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation
Chen, C.-W., Zhang, L., Dutta, R. K., Niroula, A., Miller, P. G., Gibson, C. J., Bick, A. G., Reyes, J. M., Lee, Y.-T., Tovy, A., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.09.011 · Cited by 28
Halik, A., Tilgner, M., Silva, P., Estrada, N., Altwasser, R., Jahn, E., Heuser, M., Hou, H., Pratcorona, M., Hills, R. K., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01590-1 · Cited by 25
Self-citationMizumaki, H., Hosomichi, K., Hosokawa, K. T., Yoroidaka, T., Imi, T., Zaimoku, Y., Katagiri, T., Nguyen, M. A. T., Tran, D. C., El‐Badry, M., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.247809 · Cited by 25
Self-citationVoso, M. T., Pandzic, T., Falconi, G., Denčić‐Fekete, M., Bellis, E. D., Scarfò, L., Ljungström, V., Iskas, M., Poeta, G. D., Ranghetti, P., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18129 · Cited by 25
Amorós-Pérez, M., & Fuster, J. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.008 · Cited by 24
CHIPing away the progression potential of CHIP: A new reality in the making
Xie, Z., & Zeidan, A. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.101001 · Cited by 22
Lim, J.-Y., Duttke, S. H. C., Baker, T. S., Lee, J., Gambino, K. J., Venturini, N. J., Ho, J., Zheng, S., Fstkchyan, Y. S., Pillai, V., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202733 · Cited by 23
How aging influences the gut-bone marrow axis and alters hematopoietic stem cell regulation
Wells, C., Robertson, T., Sheth, P. M., & Abraham, S. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32831 · Cited by 22
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
Christen, F., Hablesreiter, R., Hoyer, K., Hennch, C., Maluck-Böttcher, A., Segler, A., Madadi, A., Frick, M., Bullinger, L., Briest, F., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01469-x · Cited by 22
Self-citationFrom Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
Gurnari, C., Fabiani, E., Falconi, G., Travaglini, S., Ottone, T., Cristiano, A., & Voso, M. T. (2021) · Biology · doi:10.3390/biology10020128 · Cited by 22
Bohl, S., Schmalbrock, L. K., Bauhuf, I., Meyer, T., Dolnik, A., Szyska, M., Blätte, T. J., Knödler, S., Röhner, L., Miller, D., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003541 · Cited by 19
Self-citationClonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers
Croitoru, V. M., Cazacu, I. M., Popescu, I., Paul, D., Dima, S., Croitoru, A. E., & Tănase, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.772166 · Cited by 21
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
Kandarakov, O. F., & Belyavsky, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217902 · Cited by 22
Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
Woll, P. S., Yoshizato, T., Hellström‐Lindberg, E., Fioretos, T., Ebert, B. L., & Jacobsen, S. E. W. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13535 · Cited by 15
Compartment-specific mutational landscape of clonal hematopoiesis
Hartmann, L., Hecker, J. S., Rothenberg‐Thurley, M., Rivière, J., Jentzsch, M., Ksienzyk, B., Buck, M. C., van der Garde, M., Fischer, L., Winter, S., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01700-3 · Cited by 19
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
Lassalle, F., Duployez, N., Vincent, F., Rauch, A., Denimal, T., Rosa, M., Labreuche, J., Dombrowicz, D., Staels, B., Preudhomme, C., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.04.010 · Cited by 21
Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia
Burns, S. S., & Kapur, R. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.07.008 · Cited by 19
Murphy, T., Zou, J., Daher-Reyes, G. S., Arruda, A., Gupta, V. K., McNamara, C. J., Minden, M. D., Schimmer, A. D., Sibai, H. A., Yee, K. W. L., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000306 · Cited by 19
Clonal hematopoiesis and vascular disease
Amancherla, K. V., Wells, J. A., & Bick, A. G. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00913-z · Cited by 18
Feldkamp, J. D., Vetter, V. M., Arends, C. M., Lang, T. J. L., Bullinger, L., Damm, F., Demuth, I., & Frick, M. (2022) · Haematologica · doi:10.3324/haematol.2021.280021 · Cited by 18
Self-citationGaulin, C., Kelemen, K., & Yi, C. A. (2022) · Life · doi:10.3390/life12081135 · Cited by 16
Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndromePreprint
Ganesan, S., Murray, R. M., Sotélo, J. A. L., Eton, E. O., Takashima, K., Botella, T., Beattie, K., Indart, A. C., Chraiki, N., Croizier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.19.594376 · Cited by 18
Dederichs, T.-S., Yerdenova, A., Horstmann, H., Vico, T. A., Nübling, S., Peyronnet, R., Pfeifer, D., Muehlen, C. V. Z., Heidt, T., Wolf, D., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320183 · Cited by 17
Kállai, A., Ungvari, A., Csabán, D., Őrfi, Z., Lehoczki, A., Harasztdombi, J., Yabluchanskiy, A., Benyó, Z., Szappanos, Á., Tarantini, S., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01654-1 · Cited by 14
Li, J., Wang, C., Liu, J., Yu, Y., Liu, Y., Peng, Q., Liu, H., & Guan, X. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06370-5 · Cited by 12
Savola, P., Bhattacharya, D., & Huuhtanen, J. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2022.07.004 · Cited by 14
Javorniczky, N., Wehrle, J., Ihorst, G., Hupfer, V., Aumann, K., Pfeifer, D., Niemöller, C., Bleul, S., Pantić, M., Werner, M., et al. (2020) · Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis · doi:10.1016/j.leukres.2020.106454 · Cited by 12
Liu, Y., Xi, Z., Zhou, J., Ling, F., Zhang, Y., Xie, H., Zheng, J., Xia, B., Feng, H., & Li, Y. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1342 · Cited by 12
Spitzer, B. G., Rutherford, K. D., Gundem, G., McGovern, E. M., Millard, N. E., Ossa, J. A., Cheung, I. Y., Gao, T., Levine, M. F., Zhang, Y., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2451 · Cited by 12
Schenz, J., Rump, K., Siegler, B. H., Hemmerling, I., Rahmel, T., Thon, J. N., Nowak, H., Fischer, D. P., Hafner, A., Tichy, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968778 · Cited by 12
Osman, A. E. G., Mencia-Trinchant, N., Saygin, C., Moma, L., Kim, A., Housman, G., Pozsgai, M. J., Sinha, E., Chandra, P., Hassane, D. C., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008521 · Cited by 11
Metadata
- Authors
- Arends, C. M., Galan-Sousa, J., Hoyer, K., Chan, W., Jäger, M., Yoshida, K., Seemann, R., Noerenberg, D., Waldhueter, N., Fleischer-Notter, H., Christen, F., Schmitt, C. A., Dörken, B., Pelzer, U., Sinn, M., Zemojtel, T., Ogawa, S., Märdian, S., Schreiber, A., Kunitz, A., Krüger, U., Bullinger, L., Mylonas, E., Frick, M., & Damm, F.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Kyoto University (JP)
- Max Delbrück Center (DE)
- ORCID
- Venue
- Leukemia
- Published
- 2018-03-01
- Volume
- 32
- Issue
- 9
- Pages
- 1908-1919
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2789900003
- Cited by
- 194
- References
- 50
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 25 · 2023: 26 · 2022: 31 · 2021: 30 · 2020: 20 · 2019: 27 · 2018: 6
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Leukemia (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- clonal hematopoiesis of indeterminate potential, clonal hematopoiesis, variant allele frequency, DNMT3A, hematopoietic stem cells, chemotherapy, hematologic cancer, red blood cell transfusion
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Alleles, Cell Differentiation, DNA Mutational Analysis, Female, Gene Frequency, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Middle Aged, Mutation, Biomarkers, Immunophenotyping, Polymorphism, Single Nucleotide, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review